NERCE / BEID www.nerce.med.harvard.edu New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research.

Slides:



Advertisements
Similar presentations
Responding to the Threat of Bioterrorism: A Status Report on Vaccine Research in the United States Good Morning. Over the next 1 ½ hours of so I’ll be.
Advertisements

Infectious Diseases. Nature of infectious diseases Pathogens Infection Disease In order to cause disease, pathogens must be able to enter, adhere, invade,
CHAPTER 27 Animal-Transmitted, Arthropod- Transmitted, and Soilborne Microbial Diseases.
GIS in a context of Bioterrorism Maria Styblińska University of Silesia Institute of Informatics.
Regional Centers of Excellence Academic defense against bioterrorism.
BIOTERRORISM health preparedness
NIAID BioDefense Research: Challenges, Opportunities, & Sustainability
Highly containment laboratory in the National Institute of Infectious Diseases, Tokyo, Japan: activities, circumstances, and future challenges Masayuki.
The Science of Agroterrorism Bob L. Larson, DVM, PhD, ACPVM University Extension, Commercial Agriculture Program, Beef Focus Team University of Missouri,
Mechanisms of Pathogenicity Microbiology 2314 Definitions Pathogenicity The ability of a pathogen to produce a disease by overcoming the defenses of.
Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.
Northwest Center for Public Health Practice University of Washington School of Public Health and Community Medicine 1 Preparing for and Responding to Bioterrorism:
Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP 25 October 2013.
Medical Diagnostics NIAID Funding Opportunities Maria Y. Giovanni, Ph.D. Assistant Director for Microbial Genomics and Advanced Technologies National Institute.
Biodefense-related Research UMDNJ-New Jersey Medical School Nancy Connell, Ph.D. Director, UMDNJ Center for Biodefense Vice-chair for Research Department.
The Battle Against Disease 4-H Veterinary Science Extension Veterinary Medicine Texas AgriLife Extension Service College of Veterinary Medicine and Biomedical.
Infectious Diseases & Biodefense at UVa Biodefense and infectious diseases in 2008 will move into the new Carter- Harrison Research Building –23,800 nsf.
NIAID Bioinformatics Resource Centers Valentina Di Francesco Bioinformatics Program Director Microbial Genomics Program, DMID.
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research.
What will be studied? What are the risks? Part II October 1, 2007 National Emerging Infectious Diseases Laboratories.
Division of Emerging and Transfusion Transmitted Diseases Bioterrorism Preparedness Initiatives Hira L. Nakhasi, Ph.D.
Bacterial Toxins Chapter 14 Add-on.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Daniel Kollek, MD, CCFP(EM)
Mass Disaster: Past and Present Current Trends: 5 th Annual Conference December 1, 2004 Nizam Peerwani, M.D. Chief Medical Examiner Tarrant-Denton-Parker.
The Global Threat of Infectious Diseases Background 20 th Century Re-Emergence of Infectious Diseases - Newly recognized diseases - Known diseases -
Overview of the Laboratory of Respiratory and Special Pathogens Michael Schmitt, Ph.D. Chief, Laboratory of Respiratory and Special Pathogens.
US biosafety experiences during the last two decades: Lessons and achievements PETER PALESE MOUNT SINAI SCHOOL OF MEDICINE, New York BIOSECURITY, ISTANBUL,
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
Weaponized Bioagents YSU – Agents of Mass Casualty.
SHAHID ALI Ph.D Scholar (Botany) 08-arid-954
Transmitted Microbial Diseases Zoonoses Epizootic Endozootic Rabies Negri bodies Rabies Cases.
A vaccine is biological preparation that improves immunity to a particular disease, a vaccine typically contains a disease causing micro-organisms often.
Infectious Diarrheas - Overview Greatest cause of morbidity and mortality worldwide Scope of disease: 1993, E.coli 0157:H Cyclospora 1998.
1 Goals for EH&S Discussion  Regulatory Environment after 9/11 and impact on university EH&S and Campus Police operating procedures.
Microbial Hazards. Microorganisms are everywhere -- they can be: – Pathogens – cause disease – Spoilers – cause the quality of food to deteriorate – Beneficial.
Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP.
Infectious Diseases Chapter 20, section 2. Disease is a major focus of environmental health Two categories: transmissable (or infectious) disease – can.
T Rare Diseases t Never Seen or Diagnosed by Today’s Clinicians t Non-traditional Routes of Infection t Emerging Patterns of Resistance t Increased Virulence.
New Developments in Biothreats and Biosecurity Clifton R. Lacy, M.D. October 17, 2007.
Humans and the Microbial World Chapter 1. What is a Microorganism? 1.Definition 2.Prokaryotic or Eukaryotic? 3.Unicellular or Multicellular?
BIOTERRORISM June 15, 2006 Christina M. Cabott D.O.
Emerging and Re-emerging Infectious Diseases Samantha Rosenthal, MPH, PhD Candidate.
What’s Bugging You? A Cyberhunt Activity on Infectious Disease By Dawn Hall for Biomedical Technology.
Biological Warfare -How biology involved in human conflict-
A. Discovery of New Genes related to Leishmania Pathogenesis and as Biomarkers of Attenuation Using a Genomic Microarray B. Multiplex PCR Microarray Assay.
Robert Gay, ACVCSD.  Pierce through the skin to obtain blood meals  Feed from one host to another host without discrimination.
Unit 6 – Organismal Biology Part 1: Bacteria and Viruses
Patrick J. Scannon, M.D., Ph.D. CSO, XOMA Stanford University, October 2015 Technology Impact on Biosecurity Policy and Practice “D.A. Henderson, Scientist.
CHLAMYDIA, RICKETTSIA AND MYCOPLASMA.
Biology II Diseases caused by Bacteria and Viruses.
BME 301 Lecture Eight. Review of Lecture 7 Science “Science is the human activity of seeking natural explanations for what we observe in the world around.
Rational Strategies Interventions of choiceInterventions of choice Economic, social and other non-medical countermeasures Interventions of last resortInterventions.
Diseases in Nature Conference John Herbold DVM, MPH, PhD, DACVPM, FACE Center for Biosecurity & Public Health Preparedness University of Texas School of.
Disaster Nursing. Bioterrorism and Weapons of Mass Destruction By: Brittney Mathis.
روش استاندارد انتقال نمونه هاي عفوني براساس الزامات بين المللي.
Microbial toxin There are several virulence factors which help to establish disease The virulence of some bacteria is thought to be aided by the production.
The National Oversight of Bioscience Researches in Korea : Biosafety & Biosecurity WK Seong, CK Yoo, JK Lee, JB Ahn, and TJ Son Division of Biosafety Evaluation.
Bioterrorism and Food Laws FST /25/02 by David Rasmussen.
Bioterrorism Agents Epidemiology Program Overview.
Stanford University Dual Use Research of Concern in the Life Sciences
Bioterrorism: A Changing World and What You Can Do
Emerging Infectious Diseases:
INTRODUCTION TO MEDICAL MICROBIOLOGY & IMMUNOLOGY
Joel G. Breman, MD, DTPH Fogarty International Center
Overview of Terrorism Research at the CDC
BIOE 301 Lecture Eight.
Presentation transcript:

NERCE / BEID New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research

NERCE / BEID NIAID Strategic Plan –Category A, B, and C Priority Pathogens –Biology of the Microbe –Host Response – Diagnostics –Vaccines –Therapeutics – Research Resources »Regional Centers of Excellence »National Biocontainment Laboratories »Regional Biocontainment Laboratories

NERCE / BEID NIAID Priority Pathogens Category A  Bacillus anthracis (anthrax)  Clostridium botulinum  Yersinia pestis  Variola major (smallpox)  Francisella tularensis (tularemia)  Viral hemorrhagic fevers  Arenaviruses  Bunyaviruses  Hantaviruses  Rift Valley Fever  Flaviruses  Dengue  Filoviruses  Ebola  Marburg Category B  Burkholderia pseudomallei  Coxiella burnetti (Q fever)  Brucella species (brucellosis)  Ricin toxin (from Ricinus communis)  Epsilon toxin of Clostridium perfringens  Staphylococcus enterotoxin B  Typhus fever (Rickettsia prowazekii)  Food and Waterborne Pathogens  Bacteria  Diarrheagenic E.coli  Vibrio cholera  Salmonella  Viruses (Caliciviruses, Hepatitis A)  Protozoa  Cryptosporidium parvum  Additional viral encephalitides  West Nile Virus  EEE

NERCE / BEID Academic / Industry Partnership

NERCE / BEID New England Regional Center of Excellence All medical schools in New England contribute to governance and strategic planning Institutions currently with active major research projects: –Boston University Medical Center –Center for Blood Research –Harvard Medical School –University of Massachusetts – Dartmouth –University of Massachusetts Medical School –Brigham and Woman’s Hospital –Dartmouth Medical School

NERCE Strategic Plan -NERCE will provide the nation, as quickly and efficiently as possible, with vaccine and therapeutic interventions against infections caused by organisms used as weapons of bioterrorism -NERCE is using a genomics, proteomics, and high-throughput approach to biodefense development

NERCE / BEID NERCE Components 6 Research Programs 5 Developmental Projects Program 4 Core Laboratories / Programs 2 Career Development Programs Emergency Response Plan Regional and National Governance Committees

NERCE / BEID NERCE Research Programs Multiple Approaches to Blocking Toxin Action –Direct Inhibition of Anthrax Toxin Action John Collier, PI –Direct Blocking of Botulinium Toxin Action Bal Ram Singh, PI –Disruption by Small Molecules of Intracellular Toxin Transport Tomas Kirchhausen, PI –Mechanism(s) of Endocytic Vesicle Membrane Translocation by Diptheria Toxin, Anthrax Toxin, and Botulinium Neurotoxins Jack Murphy, PI

NERCE / BEID NERCE Research Programs Mediators and Inhibitors of Immunity to Yersinia pestis Michael Starnbach and John Goguen, PIs Microbial Vectors for Antigen Delivery John Mekalanos, David Knipe, and Darren Higgins, PIs Development of a Conjugate Vaccine for the Prevention of Tularemia Arthur Tzianabos and Dennis Kasper, PIs

NERCE / BEID NERCE Research Programs Discovery of Small Molecules to Block Fusion by Envelope Proteins of Dengue and Ebola Viruses Stephen Harrison, PI Innate Immunity to Hemorrhagic Fever Viruses Robert Finberg and Douglas Golenbock, PIs

NERCE / BEID NERCE Developmental Projects Studies of the SARS Receptor ACE2 Michael R. Frazan, PI Structure of Anthrax Spore Polysaccharide Julia Wang, PI SARS Coronavirus Pathogenesis in African Green Monkeys Keith G. Mansfield, PI Development of a Multi-gene Subunit-based smallpox vaccine Shan Lu, PI Novel Ways to Optimize CTL Response to Vaccinia Virus William R. Green, PI

NERCE / BEID NERCE Core Laboratories BSL-3 Animal and Tissue Culture Andrew Onderdonk, PI Proteomics Leonardo Brizuela, PI Harvard Institute of Proteomics Small Molecule Screening Steven Lory, PI Institute for Chemistry and Cell Biology Clinical Studies Raphael Dolin, PI

NERCE / BEID Career Development Program RFP Issued October 14 Applications due December 1 Funding Start March 1

NERCE / BEID Emergency Response Plan Provide facilities and scientific support to first- line responders in the event of a biodefense or naturally occurring biological emergency –Independent local confirmatory testing of a positive test result derived from Project BioWatch –Scientific expert resource –Laboratory testing consulting services, auxiliary sample testing, and sample storage and archiving

NERCE / BEID Regional Centers of Excellence Duke University Harvard Medical School New York State Department of Health University of Chicago University of Maryland University of Texas Medical Branch University of Washington Washington University in St. Louis

NBLs and RBLs National Biocontainment Laboratories –Boston University –University of Texas Medical Branch Regional Biocontainment Laboratories –Colorado State University –Duke University –Tulane University –University of Alabama at Birmingham –University of Chicago –University of Medicine and Dentistry of New Jersey –University of Missouri –University of Pittsburgh –University of Tennessee

NERCE / BEID Assembly and Action of Anthrax Toxin

NERCE / BEID Screening for chemicals that protect cells from anthrax toxin Cell Viability